Zhou Xin, Zhang Jimin, Feng Guowei, Shen Jie, Kong Deling, Zhao Qiang
Institute of Molecular Biology, Nankai University, Tianjin 300071, PR China.
College of Life Sciences, Nankai University, Tianjin 300071, PR China.
Curr Med Chem. 2016;23(24):2579-2601. doi: 10.2174/0929867323666160729104647.
Nitric oxide (NO), as an essential signaling molecule, participates in various physiological processes such as cardiovascular homeostasis, neuronal transmission, immunomodulation, and tumor growth. The multiple role of NO in physiology and pathophysiology has triggered a massive interest in the strategies of delivering exogenous NO for biomedical applications. Hence, different kinds of NO prodrugs have been developed up to date, including diazeniumdiolates, S-nitrosothiol, metal-nitrosyl, nitrobenzene, and so on. However, the clinical application of these low molecular weight NO donors has been restricted due to the problems of burst release, low payloads, and untargeted delivery. The delivery of NO by biomaterialbased carrier offers a beneficial strategy to realize the controlled and sustained delivery of NO to the targeted tissues or organs. In detail, NO-donor prodrugs have been attached and loaded to diverse biomaterials to fabricate nanoparticles, hydrogels, and coating platforms by means of physical, chemical, or supramolecular techniques. These NO-releasing biomaterials hold promise for a number of biomedical applications ranging from therapy of the ischemic disease and several types of cancer to cardiovascular devices and wound dressing. First, surface coating with NO-releasing biomaterials could mimic the physiological function of vascular endothelium, therefore promoting vascularization and improving the patency of cardiovascular implants. Next, because NO also mediates many important processes that take place after cutaneous injury, NO-releasing biomaterials could serve as ideal wound dressing to accelerate tissue regeneration. Finally, biomaterials enable localized delivery of high dose of NO to tumors in a sustained manner, thus generating potent tumoricidal effect. In this review, we will summarize the progress of different NO-releasing biomaterials, and highlight their biomedical applications with a hope to inspire new perspectives in the area of biomaterial-based NO-delivery systems.
一氧化氮(NO)作为一种重要的信号分子,参与多种生理过程,如心血管稳态、神经传递、免疫调节和肿瘤生长。NO在生理和病理生理中的多重作用引发了人们对用于生物医学应用的外源性NO递送策略的极大兴趣。因此,迄今为止已开发出不同种类的NO前药,包括二氮烯二醇盐、S-亚硝基硫醇、金属亚硝酰基、硝基苯等。然而,由于爆发释放、低载药量和非靶向递送等问题,这些低分子量NO供体的临床应用受到了限制。基于生物材料的载体递送NO为实现向靶向组织或器官可控和持续递送NO提供了一种有益的策略。具体而言,NO供体前药已通过物理、化学或超分子技术附着并负载到各种生物材料上,以制备纳米颗粒、水凝胶和涂层平台。这些释放NO的生物材料在从缺血性疾病和几种癌症的治疗到心血管装置和伤口敷料等许多生物医学应用中具有前景。首先,用释放NO的生物材料进行表面涂层可以模拟血管内皮的生理功能,从而促进血管生成并改善心血管植入物的通畅性。其次,由于NO还介导皮肤损伤后发生的许多重要过程,释放NO的生物材料可以作为理想的伤口敷料来加速组织再生。最后,生物材料能够以持续的方式将高剂量的NO局部递送至肿瘤,从而产生强大的杀肿瘤作用。在本综述中,我们将总结不同释放NO生物材料的进展,并突出它们的生物医学应用,希望能激发基于生物材料的NO递送系统领域的新观点。